Lyudmyla Berim
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer (NCT04672005) | Lyudmyla Berim | 2021-01-06 |
Track Lyudmyla Berim automatically
Every clearance here is in the API, with alerts when new ones post.